Search
for

    Sort by

    Research 481–510 of 1000+

    1. Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis Clinical Journal of Gastroenterology · 2026
    2. Modern Management Approaches for Alopecia Areata Вопросы современной педиатрии · 2025
    3. Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications Journal of Skin and Sexually Transmitted Diseases · 2026
    4. New Treatments for Hair Loss Actas Dermo-Sifiliográficas · 2017 · 7 citations
    5. Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control Clinical Cosmetic and Investigational Dermatology · 2026
    6. Ritlecitinib: First Approval Drugs · 2023 · 84 citations
    7. Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy Dermatology Review · 2016 · 4 citations
    8. Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions ADMET & DMPK · 2025
    9. Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis Galen Medical Journal · 2025
    10. The role of lymphocytes in the development and treatment of alopecia areata Expert Review of Clinical Immunology · 2015 · 60 citations
    11. Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies Dermatology and Therapy · 2024 · 1 citations
    12. Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis Clinical Cosmetic and Investigational Dermatology · 2026
    13. Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies Frontiers in Pharmacology · 2026
    14. Immune Microenvironment of Hair Follicles in Tumor Immunotherapy ImmunoTargets and Therapy · 2026
    15. Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique HAL (Le Centre pour la Communication Scientifique Directe) · 2025
    16. Studi Molecular Docking Aktivitas Anti Alopecia pada Senyawa yang Terkandung dalam Daun Dadap Serep (Erythrina subumbrans (Hassk.) Merrill) FASKES Jurnal Farmasi Kesehatan dan Sains · 2025
    17. Evolution of Ritlecitinib Population Pharmacokinetic Models During Clinical Drug Development Clinical Pharmacokinetics · 2023 · 6 citations
    18. Estimation of health utility values for alopecia areata Quality of Life Research · 2024 · 4 citations
    19. Roles of tumor suppressors in regulating tumor-associated inflammation Cell Death & Differentiation · 2014 · 44 citations
    20. iNOS inhibits hair regeneration in obese diabetic (ob/ob) mice Biochemical and Biophysical Research Communications · 2018 · 3 citations
    21. Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation 2025
    22. Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction Archives of Dermatological Research · 2017 · 27 citations
    23. Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review Prostate Cancer and Prostatic Diseases · 2021 · 21 citations
    24. Progeria (Hutchinson-Gilford Syndrome): Literature Review and Clinical Case Вопросы современной педиатрии · 2022 · 1 citations
    25. Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts Forum Dermatologicum · 2026
    26. Unraveling Ritlecitinib: an in-depth analysis of JAK3 inhibitor for the treatment of alopecia areata Expert Opinion on Drug Metabolism & Toxicology · 2024 · 2 citations
    27. 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata 2023
    28. ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata Figshare · 2026
    29. ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata Figshare · 2026
    30. Tyrosine kinase Inhibitors in Dermatology: A Systemic Review Journal of dermatology and dermatitis · 2021 · 1 citations